TGR63 as a potential drug candidate for the treatment of Alzheimer’s Disease

Dr. Sourav Samanta’s interview with Bio Patrika hosting “Vigyan Patrika”, a series of author interviews. The author, Dr. Sourav Samanta, was born on May 1st, 1991, at Natibpur, West Bengal, India. After his initial schooling at Natibpur Bhudeb Vidyalaya, he obtained his Bachelor’s degree in Chemistry in 2013 from Bangabasi College under Calcutta University, India. He obtained his Master Degree in Chemistry in 2015 from the Department of Chemistry, Indian Institute of Technology Guwahati (IIT Guwahati), Assam, India. He joined the New Chemistry Unit (NCU), Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bangalore, India, for the PhD program in August 2015 under the guidance of Prof. T. Govindaraju. He received his Doctor of Philosophy (PhD) degree in Chemistry from JNCASR in February 2021. Currently, he is appointed as a postdoctoral research associate (PRA) under the supervision of Prof. T. Govindaraju at JNCASR. Here, Sourav talks his first author wort titled ‘Naphthalene Monoimide Derivative Ameliorates Amyloid Burden and Cognitive Decline in a Transgenic Mouse Model of Alzheimer’s Disease’ publishd in Adv Therap (2021).

Job opening in Shilps Sciences

Shilps Sciences is looking for Master/PhD candidate with strong background in Cell based assays. Hands on experience on mammalian cell culture and immune assay development is required for this role. A sound theoretical foundation in cell biology, coupled with exposure to application areas like immunology, proteomics, cancer biology, molecular biology and microbiology would be a big plus.

Re-inventing drug discovery by targeting biomolecular condensates

We gained exponential growth in technology over the past few decades, but the field of drug discovery has remained relatively stagnant. There is a need for re-inventing the drug discovery process with disruptive innovations. The term “disruptive innovation” first coined by Clayton M. Christensen in 1995, describes the innovations that significantly affect the way aContinue reading “Re-inventing drug discovery by targeting biomolecular condensates”